Case Report: PD-1 Blockade Combined Autologous Hematopoietic Stem Cell Transplantation With Modified BEAM Regimen Containing High-Dose Cytarabine to Treat R/R Hodgkin's Lymphoma

The emergence of new drugs has provided additional options in the treatment of relapsed and refractory (R/R) Hodgkin's lymphoma (HL). However, the use of autologous stem cell transplantation (ASCT) has not been completely replaced in this setting. The use of anti-programmed death-1 (PD-1) antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqi, Cassady, Kaniel, Zou, Zhongmin, Zhang, Xi, Feng, Yimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293276/
https://www.ncbi.nlm.nih.gov/pubmed/34307420
http://dx.doi.org/10.3389/fmed.2021.693023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293276/
https://www.ncbi.nlm.nih.gov/pubmed/34307420
http://dx.doi.org/10.3389/fmed.2021.693023

Ejemplares similares